InvestorsHub Logo
Followers 184
Posts 21669
Boards Moderated 0
Alias Born 08/14/2011

Re: None

Wednesday, 10/05/2022 7:43:40 AM

Wednesday, October 05, 2022 7:43:40 AM

Post# of 602

First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will give a presentation and take investor meetings at the Inaugural Roth Healthcare Opportunities Conference taking place October 6, 2022, in New York City.
Details of the conference are as follows:

Event: Inaugural Roth Healthcare Opportunities Conference
Registration: https://www.meetmax.com/sched/event_88609/conference_home.html
Date: Thursday, October 6, 2022
Time: 1.15 P.M. ET
Location: The Yale Club, New York City
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FWBI News